The State Drug Administration held a meeting in Beijing to promote the inspection, control and supervision of the medical device business process. The conference emphasized that drug supervisory authorities at all levels should raise their political standing, earnestly implement the “four strictest” requirements, adhere to problem orientation, step up efforts to investigate and deal with hidden risks in the business process, severely punish illegal and irregularities, promote in-depth and practical investigation and control, and vigorously guarantee the safety of public devices.

The State Drug Administration held a meeting in Beijing to promote the inspection, control and supervision of the medical device business process. The conference emphasized that drug supervisory authorities at all levels should raise their political standing, earnestly implement the “four strictest” requirements, adhere to problem orientation, step up efforts to investigate and deal with hidden risks in the business process, severely punish illegal and irregularities, promote in-depth and practical investigation and control, and vigorously guarantee the safety of public devices.